SAFETY AND EFFECTIVENESS OF AN AGGRESSIVE AND INDIVIDUALIZED BATH-PUVA REGIMEN IN THE TREATMENT OF PSORIASIS

被引:45
作者
CALZAVARAPINTON, PG [1 ]
ORTEL, B [1 ]
HONIGSMANN, H [1 ]
ZANE, C [1 ]
DEPANFILIS, G [1 ]
机构
[1] UNIV VIENNA,DIV SPECIAL & ENVIRONM DERMATOL,VIENNA,AUSTRIA
关键词
PSORIASIS; PUVA; BATH THERAPY;
D O I
10.1159/000246849
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The optimal therapeutic regimen of bath-PUVA therapy of psoriasis is still under debate. Objective: We investigated the safety and efficacy of an aggressive and individualized bath-PUVA regimen. Methods: Two closely matched groups of 22 psoriatic patients were treated either with 30-min baths in 0.0003% 8-methoxypsoralen (8-MOP) aqueous solution or oral administration of the drug. According to the standard European regimen, treatments were delivered 4 times a week starting with the minimal phototoxic dose. Results: Complete clearing or marked improvement was observed in all the patients. However, with bath-PUVA, the same therapeutic effect required smaller cumulative UVA doses (39.3 +/- 15.8 vs. 123.8 +/- 39.9 J/cm(2)) and lower numbers of exposures (15.2 +/- 4.4 vs. 20.6 +/- 4.2). Both differences were significant at the 0.01 level (Student's t test). Gastro-intestinal side-effects were of course restricted to oral 8-MOP. The incidences of bums and pruritus were similar. Conclusion: Using an aggressive and individualized schedule, bath-PUVA therapy showed a greater efficacy than oral PUVA therapy while being just as safe.
引用
收藏
页码:256 / 259
页数:4
相关论文
共 17 条
[1]  
BAKER H, 1986, TXB DERMATOLOGY, V1, P355
[2]   PHOTOTESTING AND PHOTOTOXIC SIDE-EFFECTS IN BATH PUVA [J].
CALZAVARAPINTON, PG ;
ORTEL, B ;
CARLINO, AM ;
HONIGSMANN, H ;
DEPANFILIS, G .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 28 (04) :657-659
[3]  
COLLINS P, 1992, BRIT J DERMATOL, V127, P392
[4]   BATH-WATER DELIVERY OF 8-METHOXYPSORALEN THERAPY FOR PSORIASIS [J].
COLLINS, P ;
ROGERS, S .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1991, 16 (03) :165-167
[5]   SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID [J].
FREDRIKSSON, T ;
PETTERSSON, U .
DERMATOLOGICA, 1978, 157 (04) :238-244
[6]   TOPICAL (BATHWATER) PUVA THERAPY [J].
GANGE, RW ;
ANDERSON, RR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 16 (02) :401-402
[7]   THE WAVE LENGTH EFFECT UPON ERYTHEMAL AND CARCINOGENIC RESPONSE IN PSORALEN TREATED MICE [J].
GRIFFIN, AC ;
HAKIM, RE ;
KNOX, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1958, 31 (05) :289-295
[8]  
HANAWALT PC, 1981, P INT S PSORALENS CO, P133
[9]  
HENSELER T, 1981, LANCET, V1, P853
[10]   PUVA THERAPY FOR PSORIASIS - COMPARISON OF ORAL AND BATH-WATER DELIVERY OF 8-METHOXYPSORALEN [J].
LOWE, NJ ;
WEINGARTEN, D ;
BOURGET, T ;
MOY, LS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 14 (05) :754-760